Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MID-STEP Trial
NCT06319248Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- May 2024
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midodrine in sepsis, hypotension, sponsored by Mayo Clinic. Started May 2024; status: recruiting.
02
Drugs
midodrine
03
Conditions
sepsishypotension
Beyond the preview
Go deeper on NCT06319248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319248.